Literature DB >> 17430691

Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer.

Mark A Jenkins1, Melissa C Southey, Graham G Giles, John L Hopper.   

Abstract

We address the issue of modifiers of risk for persons who are, on average, at high risk of colorectal cancer due to carrying germline genetic mutations. We discuss how to estimate risk and assess modifiers using data from mutation-carrying families. A critical analytical issue is the adjustment for how families have been sampled (ascertainment). Only a few published studies have made appropriate adjustments and have mostly reported lifetime risks of less than 50%. Incomplete penetrance and differences in risk by subcategories are consistent with the existence of genetic and/or environmental risk -modifiers. Data from large cohorts of carriers are required to study such modifiers with precision.

Entities:  

Mesh:

Year:  2007        PMID: 17430691     DOI: 10.1007/s11912-007-0022-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  25 in total

1.  Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindreds.

Authors:  K Heinimann; H Müller; W Weber; R J Scott
Journal:  Int J Cancer       Date:  1997-06-20       Impact factor: 7.396

2.  First Amsterdam, then Bethesda, now Melbourne?

Authors:  Heinz-Josef Lenz
Journal:  J Clin Oncol       Date:  2005-08-22       Impact factor: 44.544

3.  Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.

Authors:  Wouter H de Vos tot Nederveen Cappel; Fokko M Nagengast; Gerrit Griffioen; Fred H Menko; Babs G Taal; Jan H Kleibeuker; Hans F Vasen
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

4.  Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.

Authors:  F Quehenberger; H F A Vasen; H C van Houwelingen
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

5.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 6.  Application of genetics to the prevention of colorectal cancer.

Authors:  John L Hopper
Journal:  Recent Results Cancer Res       Date:  2005

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

8.  Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.

Authors:  Barbara M Buttin; Matthew A Powell; David G Mutch; Sheri A Babb; Phyllis C Huettner; Tina Bocker Edmonston; Thomas J Herzog; Janet S Rader; Randall K Gibb; Alison J Whelan; Paul J Goodfellow
Journal:  Am J Hum Genet       Date:  2004-04-19       Impact factor: 11.025

9.  Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation.

Authors:  Jane Green; Mary O'Driscoll; Adam Barnes; Eamonn R Maher; Peter Bridge; Keith Shields; Patrick S Parfrey
Journal:  Dis Colon Rectum       Date:  2002-09       Impact factor: 4.585

10.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  4 in total

1.  Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers.

Authors:  Aung Ko Win; James G Dowty; Yoland C Antill; Dallas R English; John A Baron; Joanne P Young; Graham G Giles; Melissa C Southey; Ingrid Winship; Lara Lipton; Susan Parry; Stephen N Thibodeau; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Noralane M Lindor; Polly A Newcomb; John L Hopper; Mark A Jenkins
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

Review 2.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

3.  Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes.

Authors:  A K Win; J G Dowty; D R English; P T Campbell; J P Young; I Winship; F A Macrae; L Lipton; S Parry; G P Young; D D Buchanan; M E Martínez; E T Jacobs; D J Ahnen; R W Haile; G Casey; J A Baron; N M Lindor; S N Thibodeau; P A Newcomb; J D Potter; L Le Marchand; S Gallinger; J L Hopper; M A Jenkins
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

4.  Familial Colorectal Cancer Type X in Central Iran: A New Clinicopathologic Description.

Authors:  Mehrdad Zeinalian; Mahdi Hadian; Morteza Hashemzadeh-Chaleshtori; Rasoul Salehi; Mohammad Hassan Emami
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.